Drugs Made In America Acquisition Corp. · NASDAQ:DMAA
Karpus Management, Inc. reported a 8.19% stake in Drugs Made In America Acquisition Corp. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Karpus Management, Inc. reported a 8.19% stake in Drugs Made In America Acquisition Corp., 2,744,109 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 8.19%
- Shares
- 2,744,109
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| KARPUS MANAGEMENT, INC. | 8.19% | 2,744,109 |
Source
Related
- Drugs Made In America Acquisition Corp.
- Karpus Management, Inc.
- Drugs Made In America Acquisition Corp. shareholders
- Schedule 13G/A · Karpus Management, Inc. · Aug 14, 2026
- Schedule 13G · Karpus Management, Inc. · May 14, 2025
- Schedule 13G/A · First Trust Capital Management L.P. · Aug 14, 2026
- Schedule 13G/A · Glazer Capital, LLC · Aug 13, 2026
- Schedule 13G/A · Mizuho Financial Group Inc · Aug 13, 2026
- Schedule 13G · Feis Equities LLC · Jun 26, 2026
- Schedule 13G · Mizuho Financial Group Inc · May 14, 2026